Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fibroblast Activation Protein Inhibitor–Based Radionuclide Therapies: Current Status and Future Directions
Manish Ora, Neetu Soni, Aftab Hasan Nazar, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 7, pp. 1001-1008
Open Access | Times Cited: 15

Showing 15 citing articles:

FAPi-Based Agents in Thyroid Cancer: A New Step towards Diagnosis and Therapy? A Systematic Review of the Literature
Priscilla Guglielmo, Pierpaolo Alongi, Lucia Baratto, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 839-839
Open Access | Times Cited: 9
Small Molecule‐Drug Conjugates: Opportunities for the Development of Targeted Anticancer Drugs
Jingjing Zhang, Fanchun Hu, Ömer Aras, et al.
ChemMedChem (2024) Vol. 19, Iss. 11
Closed Access | Times Cited: 9
Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine
Francesco Giammarile, Peter Knoll, Diana Páez, et al.
Seminars in Nuclear Medicine (2024) Vol. 54, Iss. 3, pp. 340-344
Closed Access | Times Cited: 7
18F-FAPI-42 PET/CT and 18F-FDG PET/CT in Patients with Malignant Digestive System Neoplasms: A Head-to-Head Comparative Study
Min Xiong, Hongji You, Jingmin Feng, et al.
Molecular Imaging and Biology (2025) Vol. 27, Iss. 1, pp. 131-141
Open Access
FAP inhibitors: are we really using the best method to evaluate the residence time?
Michela Cortesi, Remo Guerrini, Chiara Roccatello, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Open Access
Autophagy inhibition improves the targeted radionuclide therapy efficacy of 131I-FAP-2286 in pancreatic cancer xenografts
Xingyu Liu, Danni Li, Tianbao Ma, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
The cutting edge: Promising oncology radiotracers in clinical development
Jorge D. Oldan, Martin G. Pomper, Rudolf A. Werner, et al.
Diagnostic and Interventional Imaging (2024) Vol. 105, Iss. 10, pp. 400-406
Closed Access | Times Cited: 3
Development of fibroblast activation protein-α radiopharmaceuticals: Recent advances and perspectives
Ziyue Yu, Zeng Jiang, Xuebo Cheng, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116787-116787
Closed Access | Times Cited: 3
Fibroblast activation protein (FAP)-targeted radionuclide therapy: which ligand is the best?
Rubel Chakravarty, Wenyu Song, Sudipta Chakraborty, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 10, pp. 2935-2939
Open Access | Times Cited: 8
[64Cu]Cu-FAP-NOX, a N-oxalyl modified cyclic peptide for FAP PET imaging with a flexible imaging time window
S. Liu, Jiawei Zhong, Ziqi Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 12, pp. 3651-3661
Closed Access | Times Cited: 2
211At radiolabeled APBA-FAPI for enhanced targeted-alpha therapy of glioma
Tianzhen Ye, Yuying Yu, Guofeng Qu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116919-116919
Closed Access | Times Cited: 2
Efficacy and safety evaluation of cross-reactive Fibroblast activation protein scFv-based CAR-T cells
Wenhao Niu, Binchen Wang, Yirui Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
18F-FAPI-42 PET/CT and 18F-FDG PET/CT in patients with malignant digestive system neoplasms: a head-to-head comparative study
Min Xiong, Hongji You, Jingmin Feng, et al.
Research Square (Research Square) (2024)
Closed Access
Rational Modifications on N-(4-Quinolinoyl)-Gly-2-Cyanopyrrolidine to Develop Fibroblast Activation Protein-Targeted Radioligands with Improved Affinity and Tumor Uptake
Xiayang Qiu, Qianqian Gan, Tianxiong Ji, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117011-117011
Closed Access
Development of ibuprofen-modified fibroblast activation protein radioligands to improve cancer therapy
Hui Zhou, Jiawei Zhong, Yang Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 283, pp. 117115-117115
Closed Access
Page 1

Scroll to top